phosphotyrosine has been researched along with Lymphoma, Large-Cell, Anaplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boccalatte, FE; Bosia, A; Cheng, M; Chiarle, R; Comb, MJ; D'Amico, L; Goss, VL; Inghirami, G; Jensen, ON; Lee, K; Nardone, J; Polakiewicz, RD; Riera, L; Riganti, C; Ruggeri, B; Rush, J; Voena, C | 1 |
1 other study(ies) available for phosphotyrosine and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.
Topics: Amino Acid Sequence; Antimetabolites, Antineoplastic; Carbazoles; Cell Adhesion Molecules; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; Hydroxymethyl and Formyl Transferases; Indazoles; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Microfilament Proteins; Molecular Sequence Data; Multienzyme Complexes; Neoplasm Proteins; Nucleotide Deaminases; Phenylurea Compounds; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein Interaction Mapping; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Transcription, Genetic | 2009 |